Loading the section
Prices delayed by 15 minutes
Next earnings report: 27 October 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Alkermes plc trades on Nasdaq under the ticker ALKS. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ALKS has traded between 27.00 $ and 55.67 $. As of 09 October 2026 the price stood 45.73 % of the way from the 52-week low to the high.
Over one year ALKS shares rose 29.60 %; over six months they rose 14.86 %. Volatility over 90 days is 36.13 %. Dividends are not included: this is price change only, as of 09 October 2026.
ALKS trades at a price-to-earnings ratio of 43.7, above the sector median of 24.8. Price to sales is 4.3, above the sector median of 3.9. Price to book is 3.8, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 41.10 | 41.26 | 39.11 | 40.11 | 3M |
| 07 October 2026 | 41.28 | 42.06 | 41.17 | 41.45 | 2M |
| 06 October 2026 | 42.64 | 42.71 | 41.24 | 41.65 | 2M |
| 05 October 2026 | 42.07 | 43.22 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Alkermes plc (ALKS) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 1.5bn $, net income was 241.7m $.
This summary is compiled automatically from SEC filings and exchange data.
Address:CONNAUGHT HOUSE 1 BURLINGTON ROAD, DUBLIN 4, 00000, IE
Alkermes plc reported revenue of 1.6B $ and net income of 153M $ over the last four quarters. Net margin is 9.78 %. Revenue changed by +3.21 % year over year. Earnings per share are 0.90 $. Market capitalisation is 6.7B $.
ALKS has a return on equity of 8.72 %, above the sector median of −41.68 %. Return on assets is 3.59 %, above the sector median of −32.11 %. Operating margin is 12.28 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 41.67 |
| 42.76 |
| 3M |
| 02 October 2026 | 41.03 | 41.96 | 40.32 | 41.75 | 2M |
| 01 October 2026 | 40.00 | 41.41 | 39.99 | 40.54 | 3M |
| 30 September 2026 | 40.94 | 40.94 | 39.92 | 40.52 | 3M |
| 29 September 2026 | 39.84 | 40.90 | 39.84 | 40.80 | 3M |
| 28 September 2026 | 40.71 | 40.97 | 40.04 | 40.15 | 2M |
| 25 September 2026 | 40.94 | 41.12 | 40.49 | 40.85 | 3M |
| 24 September 2026 | 42.55 | 42.55 | 40.59 | 40.79 | 3M |
| 23 September 2026 | 43.20 | 43.62 | 41.23 | 42.13 | 2M |
| 22 September 2026 | 44.39 | 44.53 | 43.08 | 43.29 | 2M |
| 21 September 2026 | 44.27 | 44.79 | 43.11 | 44.18 | 4M |
| 18 September 2026 | 46.51 | 46.53 | 43.27 | 43.39 | 7M |
| 17 September 2026 | 47.10 | 47.40 | 46.41 | 46.71 | 1M |
| 16 September 2026 | 46.64 | 47.26 | 45.79 | 46.07 | 2M |
| 15 September 2026 | 45.73 | 46.14 | 44.63 | 46.03 | 2M |
| 14 September 2026 | 46.60 | 46.60 | 45.66 | 45.83 | 2M |
| 11 September 2026 | 46.75 | 46.75 | 45.73 | 45.97 | 1M |